Tarsus Launches “Don’t Freak Out. Get Checked Out.” Campaign During Healthy Vision Month to Encourage Patients with Demodex Blepharitis to Visit Eye Care Providers
IRVINE, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced the launch of “Don’t Freak Out. Get Checked Out.”, a disease education campaign designed to encourage patients who may have Demodex blepharitis to visit their eye care provider for an eyelid check. In support of Healthy Vision Month in May, the first of its kind campaign is designed to support patients on their journey to identify the cause of their eyelid discomfort.
- Get Checked Out.”, a disease education campaign designed to encourage patients who may have Demodex blepharitis to visit their eye care provider for an eyelid check.
- In support of Healthy Vision Month in May, the first of its kind campaign is designed to support patients on their journey to identify the cause of their eyelid discomfort.
- Demodex blepharitis is caused by an overpopulation of Demodex mites, the most common ectoparasites found in humans.
- “Demodex blepharitis patients often complain of severe discomfort and can be extremely conscious of how their eyes feel all day.